SCHEMBL6568152

SCHEMBL6568152

COc1ccc(NC(=O)Nc2ccc(OC(c3ccccc3)c3ccccc3)c(C(=O)OC(C)C)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
KDM4E B2RXH2 2/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
CASR P41180 1/20 0.47
NPC1 O15118 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
KLK7 P49862 2/20 0.46
MAPT P10636 3/20 0.46
HIF1A Q16665 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
IGF1R P08069 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568011 0.91 KDM4E (0.54) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6566840 0.89 TP53 (0.51) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6566652 0.89 SNCA (0.52) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6566646 0.89 SNCA (0.52) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6565806 0.88 TP53 (0.52) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6564786 0.84 KMT2A (0.61) RAB9AMEN1KMT2AKDM4ECASR
SCHEMBL6564383 0.84 CASR (0.50) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6566525 0.84 SMN1; SMN2 (0.52) MEN1KMT2AKDM4ETP53TSHR
SCHEMBL6567928 0.84 MEN1 (0.49) RAB9AMEN1KMT2AKDM4ETP53
SCHEMBL6566667 0.83 RAB9A (0.52) RAB9AMEN1KMT2AKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 RAB9A 1322/4885MEN1 4143/4885KMT2A 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.